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Abstract: We examined whether CXCL12α improves insulin secretion by influencing the Ca2+ 
oscillation pattern and Ca2+ influx ([Ca2+]i), thereby enhancing the viability of pancreatic islet cells in 
oxidative stress. The islets of Langerhans were isolated from male OF1 mice and pretreated with 40 
ng/mL of CXCL12α prior to exposure to 7.5 µM hydrogen peroxide, which served to induce oxidative 
stress. Incubation of islets with CXCL12α induced pancreatic β-cell proliferation and improved the 
ability of β-cells to withstand oxidative stress. Consecutive treatments of isolated islets with hydrogen 
peroxide caused a decline in β-cell functioning over time, while the CXCL12α pretreatment of islets 
exhibited a physiological response to high glucose that was comparable to control islets. The attenuated 
response of islets to a high D-glucose challenge was observed as a partial to complete abolishment of 
[Ca2+]i. Treatments with increasing concentrations of CXCL12α decreased the number of Ca2+ 
oscillations that lasted longer, thus pointing to an overall increase in [Ca2+]i, which was followed by 
increased insulin secretion. In addition, treatment of islets with CXCL12α enhanced the transcription 
rate for insulin and the CXCR4 gene, pointing to the importance of CXCL12/CXCR4 signaling in the 
regulation of Ca2+ intake and insulin secretion in pancreatic islet cells. We propose that a potential 
treatment with CXCL12α could help to remove preexisting glucotoxicity and associated temporary β-
cell stunning that might be present at the time of diabetes diagnosis in vivo. 
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INTRODUCTION 
Diabetes is characterized either by a near-absolute absence (type 1 diabetes; T1D) or depletion 
(type 2 diabetes; T2D) of pancreatic β-cells that is responsible for the condition that is described 
by insufficient or impaired insulin secretion. Therefore, β-cell mass regulation and improved 
β-cell viability and function through the stimulation of insulin secretion represent a focal point 
for prospective diabetes management. 
Insulin secretion from the pancreatic β-cells induced primarily by glucose is mediated by 
the known mechanism that involves: raising the ratio of ATP/ADP, closing the ATP-sensitive 
K+ (KATP) channels leading to plasma membrane depolarization, voltage-gated calcium (Cav) 
channels activation and increased Ca2+ influx ([Ca2+]i) [1]. Finally, increased [Ca
2+]i triggers 
the exocytosis of insulin-containing granules. There is extensive literature that examines the 
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relationship between β-cell electrical activity and intracellular Ca2+ concentration, both in the 
islets of Langerhans and in isolated islet cells [2-6]. Increased glucose concentration induces 
several types of cyclical spike activity and Ca2+ oscillations with different periods in insulin-
secreting cells [7]. The Ca2+ oscillations are closely linked to multiple key aspects of β-cell 
functioning in physiological and pathological conditions. There are several Ca2+ oscillation 
types: “fast”, with a period from several seconds to one minute, “slow”, with a period ranging 
from one to several minutes and “mixed” (or compound) oscillations characterized by fast 
oscillations superimposed on slow oscillations [8]. Numerous hormones, small molecule 
agonists as well as toxins can change the Ca2+ oscillatory behavior of β-cells thereby 
influencing [Ca2+]i and insulin secretion. 
Results obtained from β-cell research recently highlighted the important role of CXC 
chemokine ligand12 (CXCL12) in enhancing β-cell viability and proliferation. This positioned 
CXCL12 as a potentially important molecule for the treatment of diabetes. CXCL12 belongs 
to the CXC group of chemokines. It was first discovered as a pre-B cell growth-stimulating 
factor [9,10] that is also important for the proper formation of multiple organ systems. It has a 
significant role in tissue development, repair and regeneration [11-13]. CXCL12 is a ligand for 
two transmembrane receptors: CXCR4 and CXCR7 [14,15]. It was shown to stimulate β-cell 
survival by preventing apoptosis via activation of the prosurvival kinase Akt, which 
consequently upregulates the expression of antiapoptotic protein Bcl-2 and phosphorylates the 
proapoptotic protein Bad [16]. Transgenic mice overexpressing CXCL12 in their β-cells are 
resistant to β-cell apoptosis and diabetes. Our laboratory revealed a CXCL12-mediated 
improvement of β-cell viability, which is based on CXCL12 antinecrotic action through the 
modulation of PARP-1 activity [17]. Furthermore, CXCL12 is involved in the regulation of 
insulin secretion [18]. Since diabetes results from an insufficient number of β-cells or a lack of 
their functionality, the important role of CXCL12 in the process of increased β-cell viability 
and boosting of insulin secretion in the pancreas is of particular interest for the potential 
treatment of diabetes. 
The present work sought to investigate if and by which mechanism CXCL12 signaling 
could confer insulinotropic effects under physiological and oxidative stress conditions in the 
intact islets of Langerhans. We hypothesized that the delivery of CXCL12 to intact mouse 
Langerhans islets would improve viability and increase insulin secretion, influencing the Ca2+ 
oscillation pattern, [Ca2+]i and overall concentration of the Ca
2+ in the cytosol. 
 
MATERIALS AND METHODS 
Animals 
All protocols followed the regulations approved by the Animal Care Committee of the 
Universidad Miguel Hernández according to national and European policies about ethics in 
animal research. Swiss albino OF1 mice (8-10 weeks old) were used. 
Isolation of mouse pancreatic islets 
Swiss albino OF1 male mice were killed by cervical dislocation and pancreatic islets were 
isolated by collagenase (Sigma, Madrid, Spain) digestion as previously described [19]. Briefly, 
islet isolation was performed in Hank’s balanced salt solution (HBSS; 115 mM NaCl, 10 mM 
NaHCO3, 5 mM KCl, 1.2 mM NaH2PO4, 25 mM HEPES, 1.1 mM MgCl2) containing 1% 
(wt/vol) bovine serum albumin (BSA; fraction V) (Sigma, Madrid, Spain) and 5 mM glucose. 
The pancreas was cannulated by infusion of a 10-mL solution of 1.0 mg/mL collagenase in 
supplemented HBSS into the common bile duct. The distended pancreas was excised, 
transferred to a flask tube and incubated at 37°C with 1.0 mg/mL of collagenase in 
supplemented HBSS for 20 min. The digestion was stopped by adding cold supplemented 
HBSS solution. Using a dissection microscope and an external light source, the islets were 
handpicked (handpicking was repeated three times). The islets were cultured in groups in RPMI 
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1640 without phenol red at 37°C in a humidified atmosphere of 95% O2 and 5% CO2 for 48 h. 
The medium was supplemented with 10% fetal bovine serum (Thermo Scientific), 2 mM L-
glutamine, 200 U/mL penicillin and 0.2 mg/mL streptomycin. To obtain single islet cell 
suspensions, the isolated islets were collected and washed in PBS before dispersal by 
mechanical shaking at 37°C for 3 min in 0.05% trypsin, 0.7 mM EDTA. The enzymatic reaction 
was stopped by the addition of RPMI 1640 culture medium, and after centrifugation at 400 x g 
for 10 min, the cells were washed in PBS and placed in the appropriate medium, depending on 
the experimental protocol. 
Pancreatic islet cell viability assay 
Viability of islet cells was determined by simultaneously staining live and dead cells using a 
two-color fluorescence staining: acridine orange (AO) and propidium iodide (PI). Live cells 
stained green, while dead cells stained red. A working solution was prepared (0.6 µl AO from 
5mg/mL and 10 µl PI from 1mg/mL stock solutions) in 1 mL PBS. Dye mix (25 µl) was added 
to the cell suspension and transferred to a microscope slide. Cells were visualized using Leica 
DMLB fluorescence microscope. 
5-bromo-2'-deoxyuridine (BrdU) incorporation 
The isolated islets were dispersed into single cells with trypsin/EDTA as described above. The 
cells were then centrifuged and resuspended in RPMI 1640 without phenol red (Cambrex, 
Belgium), which contained 10% fetal bovine serum (Thermo Scientific), 2 mM L-glutamine, 
200 U/mL penicillin and 0.2 mg/mL streptomycin. Single cell suspensions were plated on glass 
covers and cultured for 48 h in the presence of 10 µM BrdU (Sigma, Madrid, Spain). The cells 
were fixed for 2 min with 4% PFA and washed with PBS. The cells were then treated with 2 N 
HCl for 20 min at 37°C and washed three times with 0.1 M Na2B4O7 (pH 8.5). The cells were 
permeabilized with 1% Triton X-100 for 5 min. Non-specific interactions were blocked with 
PBS supplemented with 5% normal goat serum for 1 h. The cells were probed with mouse anti-
BrdU (1:20, Dako, M0744) and rabbit anti-insulin (1:200 Abcam, ab181547) antibodies 
overnight at 4 °C. After 5 consecutive washing steps, islet cells were incubated with secondary 
antibodies: goat anti-mouse Alexa Fluor 488 was used at 1:500 and goat anti-Rabbit IgG Alexa 
Fluor 594 (A-11037) was used at 5 mg/mL for 1 h at room temperature. Nuclei were stained 
with 1 µM Ethidium Homidimer-1 for 15 min at room temperature. BrdU- or insulin-positive 
cells were represented as the percentage from a total number of 1000 cells (100%) per 
coverslip. 
Calcium imaging 
The isolated pancreatic islets were incubated in the presence of 5 µM fura-2-acetoxymethyl 
ester (Fura-2 AM; Molecular Probes) for at least 1 h at room temperature in a modified HBSS 
buffer (pH 7.35), containing 120 mM NaCl, 25 mM NaHCO3, 5 mM KCl, 1.1 mM MgCl2 
supplemented with 2.5 mM CaCl2 and increasing concentrations (3, 8 or 11 mM) of D-glucose. 
Calcium records in the whole islets of Langerhans were obtained by imaging intracellular 
calcium under an inverted epifluorescence microscope (Zeiss, Axiovert 200). Images were 
acquired every ~3 s with an extended Hamamatsu Digital Camera C4742-95 (Hamamatsu 
Photonics, Barcelona, Spain), using a dual filter wheel (Sutter Instrument CO, CA, USA) 
equipped with 340 and 380 nm, 10 nm bandpass filters (Omega optics, Madrid, Spain). Data 
were acquired using ORCA software from Hamamatsu (Hamamatsu Photonics, Barcelona, 
Spain). The results were expressed as the ratios of 340 nm/380 nm wavelengths. The results 
were plotted and analyzed using commercially available software (Sigmaplot, Jandel 
Scientific). 
RT-qPCR analysis 
Isolated pancreatic islets of Langerhans served as control, nontreated or incubated in 40 ng/mL 
of CXCL12α for 30 min and 12 h. Total RNA from the control and CXCL12α-treated islets 
was extracted using the RNeasy Mini Kit (74106, Qiagen). For cDNA synthesis, 1 μg of the 
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total RNA was reverse-transcribed using the QuantiTect Rev. Transcription Kit (205311, 
Qiagen) and oligo(dT) primers. For RT-qPCR the Maxima SYBR Green/ROX qPCR Master 
Mix (Fermentas) was used. mRNA levels were quantitatively determined with an ABI Prism 
7000 Sequence Detection system (Applied Biosystems). The fragments were amplified using 
the following primer sets: upstream 5'-GATTCTTTGAGAGCCATGTC-3' and downstream 5'-
GTCTGTTGTTGCTTTTCAGC-3' for the rat Cxcl12 gene; upstream 5'-
CTGACTGGTACTTTGGGAAA-3' and downstream 5'-GGAACACCACCATCCACAGG-3' 
for the rat Cxcr4 gene; upstream 5'-ATGTGCTGCTGTATACCCTC-3' and downstream 5'-
GTGATGACGACCCACAGATC-3' for the rat Cxcr7 gene; upstream 5'-
CAAGCTGGAGAAGAATGAGG-3' and downstream 5'-TCACCTGTTCCTCAAGGGAG-3' 
for the rat Trpm2 gene; upstream 5'-AACGGCACCCTCTTACCTTT-3' and downstream 5'-
TGCTGACATAGGACCTGCTG-3' for the rat Lc type of calcium channel gene (CACNA1c); 
upstream 5'-AAGAGGACCTGGCAGATGAA-3' and downstream 5'-
TTGAGCATTTTCCTCCCAAC-3' for the rat Ld type of calcium channel gene (CACNA1d); 
upstream 5'-AGATTACTGCCCTGGCTCCT-3' and downstream 5'-
ACATCTGCTGGAAGGTGGAC-3' for the rat β-actin gene. The real-time PCR program for 
quantitative RT-PCR was as follows: an initial step at 50°C for 2 min, followed by an initial 
denaturation step at 95°C for 10 min and a subsequent two-step PCR program at 95°C for 15 s 
and at 60°C for 60 s for 40 cycles. Negative controls lacking the template were used in all RT-
qPCR reactions. The expression levels of target genes were related to the averaged expression 
level of rat β-actin as the housekeeping gene. 
Measurement of insulin secretion 
For insulin secretion, the 48-h-cultured islets were washed for 2 h with a modified HBSS buffer 
(pH 7.35) when gassed with 95% O2 and 5% CO2. Groups of 5 islets were then transferred to 
400 µl of a buffer solution containing (in mmol/L) 140 NaCl, 4.5 KCl, 2.5 CaCl2, 1 MgCl2, 20 
HEPES and the corresponding concentration of glucose (3, 8 or 11 mmol/L), with a final pH 
of 7.4. Subsequently, 100 μl of the buffer solution with the corresponding glucose 
concentration and 5% BSA was added, followed by incubation at room temperature for 3 min 
and a cool-down period of 15 min on ice. Then the medium was collected, and the insulin 
content was measured in duplicate samples via radioimmunoassay (RIA) using a Coat-a-Count 
kit (Siemens, Los Angeles, CA, USA). The protein concentration was measured using the 
Bradford dye method [20]. 
Statistical analysis 
Data are expressed as the mean±SEM. Pairwise comparisons were made using the Student’s t-
test, unless stated otherwise. A probability level of p<0.05 was considered statistically 
significant. 
 
RESULTS 
CXCL12α exerts proliferative and prosurvival effects on pancreatic islet cells 
To examine the beneficial effect of CXCL12α on pancreatic β-cells, the islets of Langerhans 
were isolated from male OF1 mice and pretreated with 40 ng/mL of CXCL12α prior to 
exposure to 7.5 µM hydrogen peroxide, which served to induce oxidative stress (Fig. 1). The 
proliferative potential of the pretreatment with CXCL12α was validated by BrdU incorporation 
for 48 h, followed by double-staining with anti-BrdU and anti-insulin antibodies (Fig. 1A). 
Statistically significant increases in the number of double-stained BrdU and insulin positive 
cells after the pretreatment of islets with CXCL12α as compared to control cells were observed 
(inset in Fig. 1A). Overnight incubation of the islets decreased cell viability to about 70%, 
whereas the treatment with hydrogen peroxide decreased cell viability further, which was 
observed as a 15% higher number of dead cells (Fig. 1B). However, when the islets were 
incubated overnight with 40 ng/mL of CXCL12α and exposed to oxidative stress, their viability 
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remained at the control level. This result shows that CXCL12α provided for an increased 
proliferative potential and improved the ability of β-cells to withstand oxidative stress. 
CXCL12α preserves islet cell functionality by normalizing their Ca2+ response under 
oxidative stress 
To assess the functionality of β-cells under oxidative stress, we analyzed the rise in [Ca2+]i that 
primes cells for insulin release. [Ca2+]i served as a dynamic parameter of islet functionality in 
response to stimulatory glucose concentration. In our experimental setup, we first examined 
whether a 7.5-µM concentration of hydrogen peroxide influences [Ca2+]i. Isolated islets were 
preloaded with Fura-2 AM and subjected to calcium imaging (Fig. 1C). Exposure to hydrogen 
peroxide completely abolished the influx of Ca2+ so that the glucose-induced [Ca2+]i response 
to 11 mM of D-glucose was clearly decreased. As shown on Fig. 1C, the initial Ca2+ spike 
observed after the first hydrogen peroxide injection and D-glucose stimulation was absent; 
however, some oscillations could still be detected. The second hydrogen peroxide treatment of 
the same islet and exposure to 11 mM of D-glucose did not provoke a rise in [Ca2+]i, indicating 
unresponsiveness of the islet cells to glucose stimulus. 
To check whether CXCL12α increases cell viability by influencing Ca2+ influx, isolated 
islets were incubated overnight with 40 ng/mL of CXCL12α, preloaded with Fura-2 AM and 
subjected to calcium imaging. Islet viability was challenged with 25 mM KCl, which 
depolarizes the cell membrane and impedes Ca2+ influx. The control islets exhibited the usual 
response to a high glucose challenge, observed as an increase in intracellular Ca2+ concentration 
(Fig. 2A). In contrast, islets treated with 7.5 µM hydrogen for 1 h exhibited decreased 
responsiveness to the high D-glucose treatment (Fig. 2B), displayed as an irregular Ca2+ spike 
followed by an oscillatory pattern. When the same experimental setup was applied to islets that 
were incubated overnight with 40 ng/mL of CXCL12α prior to exposure to 7.5 µM hydrogen 
peroxide for 1 h (Fig. 2C), the CXCL12α-pretreated islets exhibited a physiological response 
to high glucose that was comparable to the response elicited in control islets. The protective 
capacity of CXCL12α was further tested on islets that were exposed to a 10-fold higher 
concentration (75 µM) of hydrogen peroxide. This concentration of hydrogen peroxide, which 
induced a high level of oxidative stress, initiated widespread cell death, so that the islet cells 
were unable to properly respond to the high D-glucose concentration (Fig. 2D). The 
pretreatment of islet cells with CXCL12α did not preserve cell functionality at the level of 
oxidative stress induced by 75 µM hydrogen peroxide (Fig. 2E). 
CXCL12α modulates Ca2+ oscillations in islet cells in response to high glucose 
The deterioration of pancreatic β-cell function over time in T2D is the consequence of poor 
glycemic control and the continuous exposure of β-cells to the deleterious effects of reactive 
oxygen species (ROS). We examined whether CXCL12α could improve the response of 
pancreatic islet cells in the hyperglycemic state. To that end, [Ca2+]i was monitored in isolated 
islets preloaded with Fura-2 AM (Fig. 3). As can be seen in Fig. 3A, when islets were treated 
with 3 mM of D-glucose supplemented with 40 ng/mL of CXCL12α, their intracellular Ca2+ 
concentration did not change, and islet functionality was preserved, which was confirmed by 
their response to the high, 11-mM D-glucose concentration. When islets were exposed to a 
moderate to high, 8-mM D-glucose concentration (Fig. 3B), the initial Ca2+ spike was followed 
by continuous oscillations as a result of the repeated entry of Ca2+. A mix of 8 mM D-glucose 
and 40 ng/mL of CXCL12α induced changes in the mode of Ca2+ entry and overall [Ca2+]i, 
manifesting as an oscillatory pattern with longer-lasting oscillations with a lower frequency. 
Calculation of the overall Ca2+ uptake revealed that CXCL12α modulated Ca2+ influx, resulting 
in increased [Ca2+]i (inset in Fig. 3B). The same result was obtained when islet cells were 
challenged with 11 mM of D-glucose (Fig. 3C). In this setup, the islets were probed with 11 
mM D-glucose, as well as in combination with two CXCL12α concentrations (20 and 40 
ng/mL). Treatments with both CXCL12α concentrations decreased the number of oscillations 
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that also lasted longer, which pointed to an overall increase in [Ca2+]i (inset in Fig. 3C), with 
the 40-ng/mL CXCL12α concentration showing a more significant effect. 
CXCL12α signaling influences the expression of voltage-gated Ca2+ channels in 
pancreatic islets 
The voltage-gated calcium (Cav) channels in β-cells are molecular switches that play a central 
role in insulin secretion. The observation that CXCL12α is capable of modifying Ca2+ 
oscillations and increasing [Ca2+]i led us to assume that the CXCL12α/receptor axis regulates 
the behavior of the Cav channels. To examine this further, isolated islets were incubated either 
for 30 min or overnight with 40 ng/mL of CXCL12α, and their mRNA was isolated (Fig. 4). 
CXCL12 acts via two receptors, CXCR4 and CXCR7. RT-qPCR experiments revealed that the 
mRNAs encoding for both receptors were significantly increased after the 30-min incubation 
of islets with CXCL12α (Fig. 4). The overnight incubation with CXCL12α induced a 2-fold 
increase in CXCR4 mRNA, while the level of CXCR7 mRNA was unchanged. This result 
revealed that CXCR7 gene transcription was considerably lower in islets as compared to 
CXCR4 gene transcription. Further, RT-qPCR experiments revealed that CXCL12α also 
induced insulin mRNA synthesis in islet cells. The exposure of islets to CXCL12α for 30 min 
induced a 4-fold increase in insulin mRNA synthesis, while overnight islet incubation with 
CXCL12a did not cause a significant increase in insulin gene transcription. 
Next, we analyzed the expression of voltage-gated L-type Ca2+ channels that belong to 
the high-threshold type of channels and are opened by large depolarizations, that contribute to 
the β-cell Ca2+ current and insulin secretion. After the 30-min incubation with CXCL12α, the 
mRNAs for both Lc and Ld subtypes were significantly increased (2.5- and 6-fold, 
respectively). The overnight incubation with CXCL12α induced less pronounced but 
significant increases in Lc and Ld mRNAs (Fig. 4). We also analyzed the Ca2+-permeable, 
nonselective cation channel TRPM2, which is gated by intracellular ADP-ribose and has a key 
role in hydrogen peroxide-induced Ca2+ transients and cell death [21]. In pancreatic islets under 
physiological conditions, TRPM2 mRNA was barely detectable. After the 30-min incubation 
with 40 ng/mL of CXCL12α, a small, insignificant increase was observed (Fig. 4), and after 
the overnight incubation with CXCL12α, a significant decrease in TRPM2 gene transcription 
was measured, pointing to the prosurvival effect of CXCL12α in islet cells. 
CXCL12α stimulated insulin release in the hyperglycemic state 
An increase in blood glucose concentrations induces a series of cellular events leading to the 
depolarization of the β-cell plasma membrane that opens CaV channels to mediate Ca2+ influx 
and stimulate insulin secretion. In the next set of experiments we examined whether the 
increase in [Ca2+]i, observed after the incubation of pancreatic islets with CXCL12α, was also 
linked with insulin secretion. The islets were incubated either for 30 min (Fig. 5A) or overnight 
(Fig. 5B) with 40 ng/mL of CXCL12α, followed by treatment with 8 mM and 11 mM of D-
glucose, and their insulin secretion was measured by RIA. Under physiological conditions, in 
the presence of 3 mM of D-glucose, CXCL12α did not affect insulin secretion. Stimulatory 
glucose concentrations induced increased insulin secretion, further enhanced in the presence of 
CXCL12α (Fig. 5). Incubation with CXCL12α for 30 min induced significant insulin release 
after exposure to 8 mM and 11 mM of D-glucose (compared to matching controls, 2.18- and 
1.53-fold increases, respectively; Fig. 5A). The overnight incubation of islets with CXCL12α 
induced significant but slightly lower increases in insulin secretion after exposure to 8 mM and 
11 mM of D-glucose (compared to matching controls, 1.59- and 1.35-fold increase, 
respectively) compared to the 30-min incubation with CXCL12α (Fig. 5B). These findings 
underlined that the presence of CXCL12α in the cell medium increases insulin release in islets 
by enhancing Ca2+ uptake. 
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DISCUSSION 
Hyperglycemia contributes to the reduction of insulin secretion and to the progression from 
glucose intolerance to T2D [22], causing pancreatic β-cell dysfunction and decreasing the β-
cell mass [23,24]. Therefore, β-cell protection remains the focus of strategies for the prevention 
and treatment of diabetes [25]. In general, the diabetogenic environment, including insulin 
resistance and low-grade systemic islet inflammation contribute toward the stunning of 
pancreatic β-cells, i.e. a state of temporary incapacity to properly respond to the presence of 
increased glucose concentration by secreting insulin [26]. The aim of the present study was to 
examine whether CXCL12α exhibits a beneficial effect on pancreatic β-cells’ ability to release 
insulin and whether it improves the response of pancreatic islets in the hyperglycemic state. 
Antidiabetic action of CXCL12α: normalizing Ca2+ uptake in order to preserve the 
functionality of islets 
In overweight and obese individuals, pancreatic β-cells are exposed to metabolic changes and 
the consequences thereof, including oxidative stress resulting from increased ROS and RNS 
production. As a ligand of two receptors, CXCR4 and CXCR7, CXCL12 signaling is crucial 
for β-cell differentiation and pancreatic islet genesis [27]. Recent animal studies revealed the 
essential role of CXCL12 in duct cell survival, proliferation and migration during pancreatic 
regeneration, through its ability to activate Akt, Src and the extracellular signal-regulated 
protein kinase (ERK1/2) [28]. Our group also showed that the role of CXCL12 in diabetes 
attenuation is based on its ability to activate the antinecrotic/prosurvival pathway after 
hydrogen peroxide treatment [17]. In this study, we examined oxidative stress as a potential 
inducer of β-cell dysfunction [29]. Both effects, proliferative burst and increased survival rate 
of pancreatic β-cells, observed after islet incubation with CXCL12α could be accomplished by 
the direct influence of CXCL12 on intracellular Ca2+ influx. 
It is widely accepted that exogenous ROS induces dynamic changes in Ca2+ concentration 
in a variety of cell types [30-35]. This effect could be due to the mobilization of intracellular 
Ca2+ stores and influx of extracellular Ca2+. An important feature of cross-regulation between 
ROS and Ca2+ is that the ROS effect on Ca2+ signaling can vary from stimulatory to repressive, 
depending on the type of oxidants, their concentrations and the duration of exposure. The effect 
of ROS on Ca2+ signaling is also tissue-specific (reviewed in [36]). We found that CXCL12α 
preserves mouse islet functionality by normalizing their Ca2+ response under oxidative stress 
(hydrogen peroxide treatment). In contrast, islet cell treatment with a 10-times higher 
concentration of hydrogen peroxide (75 µM) induced a constant entry of Ca2+, which indicated 
cell death as a consequence of exposure to the very high concentration of peroxide treatment. 
This finding is in accordance with previous studies showing that hydrogen peroxide causes an 
increase in intracellular Ca2+ levels that leads to cell death in a variety of cell types [37-41]. 
The mechanism whereby hydrogen peroxide causes an increase in [Ca2+]i is still under debate, 
with several options proposed, including the involvement of voltage-gated Ca2+ channels (Cav) 
[41], nonspecific changes in membrane calcium permeability [42], alteration in Na+-Ca2+ 
exchange [38], or changes in Ca2+ release from intracellular stores [43]. Using the insulin-
secreting cell line CRI-G1 and very high hydrogen peroxide concentrations (1-10 mM), Herson 
et al. [44] described the effects of hydrogen peroxide on [Ca2+]i. They clearly demonstrated 
that hydrogen peroxide disrupts calcium homeostasis. In contrast, it has also been reported that 
hydrogen peroxide exerts no significant effect on the L-type Ca2+ current in pancreatic β-cells 
[45]. 
On the other hand, a chronic exposure of pancreatic islets to nonphysiological high 
glucose concentrations caused adverse alterations in β-cell functioning in a phenomenon 
referred to as glucose toxicity, which may play a secondary pathogenic role in T2D. Several 
results suggested that one mechanism of glucose toxicity in β-cells may be linked to chronic 
exposure of cells to ROS (or chronic oxidative stress) [46-48]. Both low and high 
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concentrations of glucose have been shown to increase intracellular peroxide levels within the 
islets [49], which indicates that glucose metabolism is essential for the induction of glucose 
toxicity. This is in agreement with Ihara et al. [50], who reported elevated levels of oxidative 
stress markers (8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins) in 
the β-cells of Goto-Kakizaki rats. Our experimental setup is suitable for observing β-cell 
behavior in hyperglycemic conditions, since chronic hyperglycemia causes a progressive 
decline in β-cell functioning and their ultimately demise [26,51]. Electrical activity and 
stimulated secretion, coupled with intracellular Ca2+ dynamics that allow pancreatic β-cells to 
secrete insulin, first reported by Dean and Matthews in 1968 [52], are nowadays accepted [53-
55]. Cells often respond to changes in stimulus intensity by varying the frequency of Ca2+ 
waves. To demonstrate the rescue potential of CXCL12α in preventing β-cell dysfunction and 
exhaustion due to sustained hyperglycemia, mouse pancreatic islets were exposed to 
stimulatory glucose concentrations, both moderate to high (8 M) and high (11 M), for an 
average duration of 45 min [56,57]. In our study, the treatment of β-cells with CXCL12α in 
hyperglycemic conditions decreased the number and duration of Ca2+ oscillations, with an 
overall increase in [Ca2+]i. It has been already shown that CXCL12 stimulates Ca
2+ flux and 
transients in many cell types [58-60]. Similar to our finding, CXCL12 dose-dependently 
increased intracellular Ca2+ in adherent IEC-6 cells in the concentrations of 20 and 100 ng/mL 
[61]. Chemokine-induced Ca2+ mobilization was not solely a function of rat intestinal epithelial 
cells, since CXCL12 stimulated a rapid increase in Ca2+ within 40 s of ligand stimulation in the 
intestinal carcinoma cell line CaCo2 cells as well [61]. In human LX2 cells, treatment with 
CXCL12 led to a nearly two-fold increase in relative Ca2+ influx, whereas in murine JS1 cells 
CXCL12 did not promote Ca2+ movement [62]. The latter authors showed that the CXCL12-
influenced hepatic stellate cell contraction is not Ca2+ dependent. In addition, the Ca2+-
influenced CXCL12 secretion has also been investigated. Schajnovitz et al. [63] reported that 
Ca2+ is transmitted via gap junctions in contacting cell cultures, and that Ca2+ signaling has a 
role in bone marrow stromal cell CXCL12 secretion. 
CXCL12α signaling influences the expression of voltage-gated Ca2+ channels in 
pancreatic islets and stimulates insulin release in the hyperglycemic state 
In a high-glucose environment and/or in the presence of ROS, voltage-gated Ca2+ (Cav) 
channels are activated, allowing extracellular Ca2+ to enter [64-67]. It is generally accepted that 
the subsequent increase in cytosolic Ca2+ triggers insulin release, even though there is some 
evidence for a [Ca2+]i-independent second phase of insulin release [68]. Thus, regulation of Cav 
activity and/or density may result in lower or higher insulin secretion [69-77]. Insulin release 
must be able to anticipate glucose increase and prevent persistent glucose elevations [26,78]. 
Insulin secretion analysis in rat insulinoma and primary islet cells revealed that N- and L-type 
channels are both involved in immediate glucose-induced insulin secretion. However, L-type 
Cav channel was preferentially coupled to secretion at a later phase. P/Q-type channels were 
not found to play any role in insulin secretion at any stage [79]. In our experimental setup, the 
exogenously added CXCL12α influenced [Ca2+]i and insulin release, promoting less frequent 
oscillations of [Ca2+]i with longer duration, and allowing more Ca
2+ to enter the islet. One 
explanation for this increase in [Ca2+]i could be linked to the ability of exogenously added 
CXCL12α to enhance gene expression of the Lc (Cav1.2-subunit)/Ld (Cav1.3-subunit) types of 
Cav, shown in our experiments. The main subtype of the L-type of channels in mouse islet β-
cells is the Ld subtype [77], although the Lc and Ld subtypes share almost a 70% homology 
[80]. In agreement with previous reports, herein we showed that CXCL12α increases the 
transcription rate of Cav L-type channels, in particular Ld-type, which contains the α1D subunit 
and represents the Cav1.3α1 channel subtype. We also observed an increase in N-type channels 
due to the increased presence of CXCL12. The increased transcriptional rate for the N-type of 
channels was significant but 7.2-fold less pronounced as compared to the increase in the 
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transcriptional rate for the L-type Cav channels (data not shown). In contrast, Barg et al. [81] 
found no differences in Ca2+-current density and Cav1.3/α1D-deficient β-cells, and concluded 
that Cav1.2 is the principal L-type Ca2+ channel subtype in mouse β-cells. The functional 
consequences of the increase in Cav channel transcription rate may be relevant in diseases, such 
as T2D, since β-cells operate with very few Cav channels [55,82]. The observed CXCL12α-
related influence could provide β-cells with a mechanism to push Ca2+-coupled regulation of 
insulin secretion in response to elevated glucose. 
Since [Ca2+]i dynamics are also responsible for β-cell fate [55], we examined whether the 
Trpm2 Ca2+ channel is upregulated due to an excess of CXCL12α. Trpm2, a calcium-permeable 
nonselective cation channel expressed in the plasma membrane is critically involved in ROS-
induced processes and is implicated in cell death [83]. In contrast to Cav channels, CXCL12α 
has no influence on the transcription rate of Trpm2 after 30 min of incubation, in contrast to 
overnight incubation, which caused a lowering of the transcription of the Trpm2 channel gene. 
The primary gating mechanism of Trpm2 involves the binding of ADP-ribose polymers 
(ADPR) [84], but Trpm2 currents can also be activated by reactive oxygen species (ROS) [85] 
through ROS-induced ADPR release from mitochondria [86]. Bearing in mind that the role of 
Trpm2 in pancreatic β-cells involves situations in which β-cells are stressed [87,88], the 
observed downregulation of Trpm2 mRNA in our experiments is not surprising. As a small 
chemokine, CXCL12 exerts its effect via coupling to its receptors, CXCR4 and CXCR7. The 
30-min incubation with CXCL12α was followed by an increase in the level of Cxcr4 mRNA. 
The increased Ca2+ influx in islet cells was accompanied by increased transcription of the Cxcr7 
and Ins. Our RT-qPCR results showed significantly increased transcription of both receptor 
genes after islet incubation with CXCL12α, targeting CXCR4 as the most important receptor 
responsible for signaling within the islet. This is in accordance with previous reports indicating 
that CXCL12 is involved in the regulation of insulin secretion [89]. β-cell injury induces 
CXCL12 expression and the secreted CXCL12 causes dedifferentiation of adjacent -cells into 
pro--cells, which are further transformed into pancreatic β-cells [18, 90]. 
β-cell Cav channel activity can be modulated by changes in membrane potential and 
through a variety of signaling pathways, such as protein phosphorylation, Ca2+-dependent 
inactivation and through interaction with G protein (reviewed in [91]). The observation that 
CXCL12α is capable to modify Ca2+ oscillations and increase [Ca2+]i as well as influence the 
transcription of Lc and Ld Ca2+ channel genes, led us to assume that the CXCL12α/receptor 
axis regulates the behavior of the Cav channels. Princen et al. [92] showed that a transient dose-
dependent increase in intracellular Ca2+ concentration is an essential component of the signal 
transduction cascade activated upon CXCL12 binding to its receptor CXCR4. The authors 
showed that in all examined CXCR4+ cell lines, CXCL12 elicited a transient [Ca2+]i increase. 
For each cell line, the magnitude of the response was related to the level of CXCR4 expression. 
Published data suggest that CXCR4 signaling may not be limited to the G-protein-coupled 
receptor (GPCR) Gαi, and that CXCR4 can couple to other Gα protein subunits such as Gαq, 
Gαo, and Gαs in order to stimulate Ca2+ flux [93]. However, it has been proven that Ca2+ flux 
is associated with the GPCR subunit Gαq but not to Gαi [94]. Quite the opposite, Hsu et al. 
[95] proposed that the L-type Cav channel in insulin-secreting cells is the major mediator of 
the somatostatin-induced inhibition of insulin secretion by the activation of G protein-coupled 
receptors. In the same line, Renstrom et al. [96] reported that stimulation of GPCRs in mouse 
islet β-cells does not influence the voltage activated Ca2+ influx. Our assumption of the 
CXCL12/receptor axis being a mediator in the elevated voltage activated Ca2+ influx in 
pancreatic β cells is supported by Roe et al. [97], who reported that decreased L-type channel 
activity and expression were associated with T2D. 
Defects in the metabolic regulation of insulin secretion contribute to the development of 
T2D. Rescuing stunned β-cells is possibly a key therapeutic target for the treatment and 
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prevention of diabetes progression. It seems reasonable to propose that bringing any degree of 
hyperglycemia under tight control as early as possible can switch on stunned β-cells, in spite 
of the fact that glycemic memory and genetic/epigenetic programming may differ in every 
individual. Identification of the factors that regulate the overall Ca2+ intake, activity and 
expression of Cav channels and insulin release may provide a better understanding of pancreatic 
β-cell functioning in normal and diabetic states. CXCL12 displayed the potential to regulate 
[Ca2+]i and the transcription of Cav channel genes and thus may serve as a potential T2D 
attenuator. 
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Figure Legends 
 
Fig. 1. CXCL12α increases pancreatic beta-cell proliferation in basal conditions and protects 
islets from hydrogen peroxide-induced cell death. A – Proliferation assay of control and islet 
cells incubated with CXCL12α (40 ng/mL) for 48 h. Cells were double-stained with anti-insulin 
(INS), displayed in red, and anti-BrdU (BrdU) displayed in green. B – Viability assay of control 
islet cells or pretreated with recombinant CXCL12α (40 ng/mL) before and after treatment with 
a 7.5-µM concentration of hydrogen peroxide. C – Alteration of [Ca2+]i of islet cells 
consecutively treated with 7.5 µM of hydrogen peroxide. Isolated islets were preloaded with 
Fura-2AM and intracellular calcium-dependent fluorescence was measured. The physiological 
response was initiated with 11 mM of D-glucose (11G) and challenged with successive islet 
treatment with 7.5 μM of hydrogen peroxide (3G-3 mM D-glucose). The insets represent one 
islet captured during the calcium imaging (a – phase contrast microscopy) stained with EtBr 
homodimer after the measurement (b). One representative result from three independent 
experiments is shown. *p value from Student’s t-test <0.05. 
 
Fig. 2. Treatment of pancreatic islets with CXCL12α preserves islet’s functionality by 
normalizing Ca2+ uptake. Intracellular Ca2+-dependent fluorescence was measured in control 
islets (A) and islets treated with a 7.5-µM hydrogen peroxide concentration (B, D) with and 
without overnight islet incubation with CXCL12α (40 ng/mL) (C, E). The islet’s membrane 
depolarization was induced with 25 mM KCl, while the islet’s physiological response was 
initiated with 11 mM of glucose. One representative result from three independent experiments 
is shown. 
 
Fig. 3. Direct stimulatory effect of CXCL12α on intracellular calcium concentration. The 
CXCL12α stimulates a dose-dependent increase in intracellular calcium. Islets were stimulated 
with 3 mM (A), 8 mM (B) or 11 mM of D-glucose (C) supplemented with or without 
CXCL12α. Ca2+ influx and number of oscillations were calculated in the same time interval (5 
min). *p value from the Student’s t-test <0.05. One representative result from four independent 
experiments is shown. 
 
Fig. 4. CXCL12α influence on gene expression for insulin, CXCR4, CXCR7, Lc/Ld and 
TRPM2 Ca2+ channels. Transcription rate (mRNA levels) of Cxcl12α, Cxcr4, Cxcr7, Lc/Ld 
types of calcium channels and Trpm2 in basal conditions and after increasing times of 
incubation with 40 ng/mL of CXCL12α was estimated by RT-qPCR. Relative mRNA levels 
are presented as the ratios of each gene/β-actin. (*) Mean values were significantly different 
from those of untreated control cells (p<0.05). Results are expressed as the means±SEM from 
three separate experiments performed in triplicate. 
 
Fig. 5. CXCL12α stimulated glucose-induced insulin release. Insulin secretion in response to 
3, 8 or 11 mM of glucose was measured in intact islets of Langerhans after 30 min (A) and 
overnight incubation (B) with CXCL12α (40 ng/mL). *p value from Student’s t-test <0.05 
**p<0.01 value from Student’s t-test. 
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